Vaxxinity Shares Rise After First Patient Dosed in Parkinson’s Study
By Sam Boughedda Investing.com — Vaxxinity Inc (NASDAQ:) inventory gained over 14.9% Wednesday after it mentioned the primary Parkinson's illness affected ...
Tag: Dosed
By Sam Boughedda Investing.com — Vaxxinity Inc (NASDAQ:) inventory gained over 14.9% Wednesday after it mentioned the primary Parkinson's illness affected ...